Morgan Stanley’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.76M | Sell |
404,357
-459,866
| -53% | -$4.28M | ﹤0.01% | 4289 |
|
|
2025
Q1 | $5.82M | Buy |
864,223
+465,356
| +117% | +$3.13M | ﹤0.01% | 3795 |
|
|
2024
Q4 | $4.24M | Buy |
398,867
+109,789
| +38% | +$1.17M | ﹤0.01% | 4137 |
|
|
2024
Q3 | $4.23M | Sell |
289,078
-82,880
| -22% | -$1.21M | ﹤0.01% | 4086 |
|
|
2024
Q2 | $4.5M | Buy |
371,958
+222,561
| +149% | +$2.69M | ﹤0.01% | 3978 |
|
|
2024
Q1 | $3.69M | Buy |
149,397
+125,087
| +515% | +$3.09M | ﹤0.01% | 4162 |
|
|
2023
Q4 | $260K | Buy |
24,310
+12,155
| +100% | +$130K | ﹤0.01% | 5847 |
|
|
2023
Q3 | $101K | Sell |
12,155
-1,311
| -10% | -$10.9K | ﹤0.01% | 5889 |
|
|
2023
Q2 | $107K | Buy |
13,466
+1,336
| +11% | +$10.6K | ﹤0.01% | 5926 |
|
|
2023
Q1 | $60.5K | Hold |
12,130
| – | – | ﹤0.01% | 6212 |
|
|
2022
Q4 | $26.8K | Sell |
12,130
-4
| -0% | -$9 | ﹤0.01% | 6552 |
|
|
2022
Q3 | $53K | Sell |
12,134
-796
| -6% | -$3.48K | ﹤0.01% | 6379 |
|
|
2022
Q2 | $41K | Sell |
12,930
-802
| -6% | -$2.54K | ﹤0.01% | 6692 |
|
|
2022
Q1 | $78K | Sell |
13,732
-64,983
| -83% | -$369K | ﹤0.01% | 6468 |
|
|
2021
Q4 | $1.02M | Buy |
78,715
+64,629
| +459% | +$837K | ﹤0.01% | 5055 |
|
|
2021
Q3 | $343K | Buy |
14,086
+2,715
| +24% | +$66.1K | ﹤0.01% | 5709 |
|
|
2021
Q2 | $196K | Buy |
11,371
+11,251
| +9,376% | +$194K | ﹤0.01% | 6026 |
|
|
2021
Q1 | $4K | Sell |
120
-2,128
| -95% | -$70.9K | ﹤0.01% | 7151 |
|
|
2020
Q4 | $22K | Buy |
+2,248
| New | +$22K | ﹤0.01% | 6404 |
|